Atherosclerotic cardiovascular disease risk and elevated lipoprotein(a) among young adults with myocardial infarction: The Partners YOUNG-MI Registry

Thanassoulis G. Screening for high lipoprotein(a). Circulation 2019; 139: 1493–1496.

Nordestgaard BG Chapman MJ Ray K , et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010; 31: 2844–2853.

Clarke R Peden JF Hopewell JC , et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009; 361: 2518–2528.

Grundy SM Stone NJ Bailey AL , et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol 2019; 73: e285–e350.

Singh A Collins BL Gupta A , et al. Cardiovascular risk and statin eligibility of young adults after an MI: Partners YOUNG-MI Registry. J Am Coll Cardiol 2018; 71: 292–302.

Cao J Steffen BT Guan W , et al. Evaluation of lipoprotein(a) electrophoretic and immunoassay methods in discriminating risk of calcific aortic valve disease and incident coronary heart disease: the multi-ethnic study of atherosclerosis. Clin Chem 2017; 63: 1705–1713.

Baudhuin LM Hartman SJ O’Brien JF , et al. Electrophoretic measurement of lipoprotein(a) cholesterol in plasma with and without ultracentrifugation: comparison with an immunoturbidimetric lipoprotein(a) method. Clin Biochem 2004; 37: 481–488.

Goff DC Jr Lloyd-Jones DM Bennett G , et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2014; 63: 2935–2959.

Mach F Baigent C Catapano AL , et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020; 41: 111–188.

Fernandez-Labandera C Calvo-Bonacho E Valdivielso P , et al. Prediction of fatal and non-fatal cardiovascular events in young and middle-aged healthy workers: the IberScore model. Eur J Prev Cardiol. Epub ahead of print 18 December 2019. DOI: 10.1177/2047487319894880.

Meirhaeghe A Montaye M Biasch K , et al. Coronary heart disease incidence still decreased between 2006 and 2014 in France, except in young age groups: results from the French MONICA registries. Eur J Prev Cardiol. Epub ahead of print 26 February 2020. DOI: 10.1177/2047487319899193.

Singh A Gupta A Collins BL , et al. Familial hypercholesterolemia among young adults with myocardial infarction. J Am Coll Cardiol 2019; 73: 2439–2450.

Yang J Biery DW Singh A , et al. Risk factors and outcomes of very young adults who experience myocardial infarction: the Partners YOUNG-MI Registry. Am J Med. Epub ahead of print 13 November 2019. DOI: 10.1016/j.amjmed.2019.10.020.

Tsimikas S Karwatowska-Prokopczuk E Gouni-Berthold I , et al. Lipoprotein(a) reduction in persons with cardiovascular disease. N Engl J Med 2020; 382: 244–255.